|
Volumn 7, Issue 2, 2005, Pages
|
A2B adenosine receptor activity is reduced in neutrophils from patients with systemic sclerosis.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE);
ADENOSINE;
ADENOSINE 5' (N ETHYLCARBOXAMIDE);
ADENOSINE A2A RECEPTOR;
ADENOSINE A2B RECEPTOR;
ADENYLATE CYCLASE;
CYCLIC AMP;
DRUG DERIVATIVE;
G PROTEIN COUPLED RECEPTOR;
PHENETHYLAMINE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
AUTOIMMUNE DISEASE;
BLOOD;
CHEMISTRY;
FEMALE;
HUMAN;
IMMUNOLOGY;
MALE;
METABOLISM;
MIDDLE AGED;
NEUTROPHIL;
PATHOLOGY;
PHYSIOLOGY;
RADIOASSAY;
SIGNAL TRANSDUCTION;
SYSTEMIC SCLEROSIS;
WESTERN BLOTTING;
ADENOSINE;
ADENOSINE-5'-(N-ETHYLCARBOXAMIDE);
ADENYLATE CYCLASE;
ADULT;
AGED;
AUTOIMMUNE DISEASES;
BLOTTING, WESTERN;
CYCLIC AMP;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEUTROPHILS;
PHENETHYLAMINES;
RADIOLIGAND ASSAY;
RECEPTOR, ADENOSINE A2A;
RECEPTOR, ADENOSINE A2B;
RECEPTORS, G-PROTEIN-COUPLED;
SCLERODERMA, SYSTEMIC;
SIGNAL TRANSDUCTION;
|
EID: 33644657348
PISSN: None
EISSN: 14786362
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (14)
|
References (0)
|